| abstract |
Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use. The invention relates to compounds of the formula I in which the radicals R and R', A, D, E, G, L, p and R1 to R1O have the stated definitions, and also to their physiologically tolerated salts. The compounds are suitable, for example, as anti-obesity drugs and for treating cardiometabolic syndrome. |